Stockscreener 앱 받기
5.95
0.00%
0.00
시간 외 거래:
5.97
0.02
+0.34%
전일 마감가:
$5.95
열려 있는:
$5.99
하루 거래량:
248.77K
Relative Volume:
0.66
시가총액:
$357.63M
수익:
$32.72M
순이익/손실:
$-54.64M
주가수익비율:
-5.2762
EPS:
-1.1277
순현금흐름:
$-55.08M
1주 성능:
-2.14%
1개월 성능:
+11.01%
6개월 성능:
+30.20%
1년 성능:
+144.86%
1일 변동 폭
$5.86
$6.17
1주일 범위
$5.75
$6.48
52주 변동 폭
$2.38
$6.48
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
명칭
Orchestra Biomed Holdings Inc
전화
646-343-9298
주소
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
5.95 | 357.63M | 32.72M | -54.64M | -55.08M | -1.1277 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 132.40B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.95B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 77.78B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.20B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 42.84B | 742.00K | -1.37B | -1.07B | -7.0731 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 개시 | TD Cowen | Buy |
| 2025-08-20 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-03-20 | 개시 | BTIG Research | Buy |
| 2025-01-02 | 개시 | Barclays | Overweight |
| 2024-08-22 | 개시 | H.C. Wainwright | Buy |
| 2024-07-25 | 개시 | B. Riley Securities | Buy |
| 2024-01-19 | 개시 | Jefferies | Buy |
| 2023-02-24 | 개시 | Piper Sandler | Overweight |
| 2023-02-07 | 개시 | Chardan Capital Markets | Buy |
모두보기
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
Orchestra BioMed Holdings, Inc. (OBIO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength? - Yahoo Finance
Orchestra BioMed Gets $6.1 Million From Vivasure Sale - mychesco.com
Liquidity Mapping Around (OBIO) Price Events - Stock Traders Daily
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026 - GlobeNewswire
Exploring These 3 Undervalued Small Caps With Insider Buying Across Regions - simplywall.st
Orchestra BioMed Highlights Pivotal Cardiovascular Program Progress - TipRanks
OBIO Maintained by B. Riley Securities -- Price Target Raised to $11.00 - GuruFocus
Orchestra BioMed Holdings Is Maintained at Buy by B. Riley Securities - Moomoo
Orchestra BioMed receives $6.1m milestone from Vivasure deal - Investing.com
Orchestra BioMed receives $6.1m milestone from Vivasure deal By Investing.com - Investing.com UK
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics - GlobeNewswire
B. Riley Adjusts Orchestra BioMed Price Target to $11 From $10, Maintains Buy Rating - marketscreener.com
Orchestra BioMed Obtains $6.1 Million Milestone Payment From Haemonetics' Acquisition of Vivasure - Yahoo Finance
Orchestra BioMed (OBIO) withholds CEO shares for taxes - Stock Titan
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday - Benzinga
BTIG upgrades Orchestra BioMed stock rating on trial progress By Investing.com - Investing.com South Africa
Orchestra Biomed Holdings Inc : Btig Raises t - Moomoo
Orchestra BioMed Shares Rise After BTIG Upgrade - marketscreener.com
Orchestra BioMed at Wells Fargo: partnership model in focus By Investing.com - Investing.com Canada
These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them? - Yahoo Finance
Crude Oil Surges 6%; Macy’s Shares Fall After Q2 Results - Benzinga
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday - Benzinga
This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
BTIG Upgrades Orchestra BioMed to Buy From Neutral, Price Target is $10 - marketscreener.com
BTIG upgrades Orchestra BioMed stock rating on trial progress - investing.com
Orchestra BioMed CEO David Hochman buys $47,900 in common stock By Investing.com - Investing.com Australia
Orchestra BioMed presents investor slide deck detailing AVIM and Virtue SAB programs, strategic partners and 2027 catalysts - TradingView
Orchestra BioMed CEO David Hochman buys $47,900 in common stock - Investing.com
Orchestra BioMed (OBIO) CEO buys more of his own stock - Stock Titan
Orchestra BioMed Grants 133,000 Options to New Hires - MyChesCo
Orchestra BioMed (OBIO) president sells 15,000 shares under trading plan - Stock Titan
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Insider plans to sell 15,000 Orchestra BioMed (OBIO) shares - Stock Titan
Orchestra BioMed (OBIO) CFO logs 3,076-share tax withholding - Stock Titan
Orchestra BioMed (NASDAQ: OBIO) exec cites tax share withholding and son's 2,000-share buy - Stock Titan
Orchestra BioMed (OBIO) officer sees shares withheld for RSU taxes - Stock Titan
Avoiding Lag: Real-Time Signals in (OBIO) Movement - Stock Traders Daily
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewswire
Insiders Buying Orchestra BioMed Holdings Might Wish They Invested More, Stock Gains 29% - Moomoo
Orchestra (OBIO) Q2 2026 Results: Profit Per Share Clears Its Benchmark for the Current Session; Investor Response: Shares Finish 19.92% Higher in Latest TradingInvestor Earnings Call - vinanet.vn
Orchestra (OBIO) Reported Results Review: EPS Prints Above Forecast for the Current Session; Price Action: Shares Close 19.92% Higher at the CloseProfit Recovery Report - vinanet.vn
Orchestra BioMed Loss Widens as Pivotal Trials Advance - MyChesCo
Orchestra Biomed Holdings Inc (OBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.06%
2.55%
자본화:
|
볼륨(24시간):